Waverley Pharma Inc. filed its Annual on Apr 29, 2022 for the period ending Dec 31, 2021. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.025 CAD | +25.00% | +25.00% | 0.00% |
May. 29 | Waverley Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 30 | Waverley Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 982K | |
+16.42% | 122B | |
+19.02% | 113B | |
+3.09% | 22.66B | |
-11.63% | 16.68B | |
-16.36% | 16.61B | |
-39.57% | 16.92B | |
+2.68% | 13.62B | |
+21.16% | 11.04B | |
+108.78% | 10.43B |
- Stock Market
- Equities
- WAVE Stock
- News Waverley Pharma Inc.
- Waverley Pharma Inc. Auditor Raises 'Going Concern' Doubt